Empozin Tablet 25 mg

About Empozin Tablet 25 mg

Empozin Tablet Uses

• Blood sugar control in type 2 diabetes
• Standalone or combination use with other diabetes medicines
• Reduced risk of heart failure hospitalization in eligible patients

Empozin Tablet Benefits

• Blood sugar lowering without directly affecting insulin release
• Modest weight reduction seen in many patients
• Added cardiovascular and kidney protection in eligible patients
• Once daily dosing that fits easily into a regular routine

What Experts Say

Empagliflozin works by blocking glucose reabsorption in the kidneys, so extra sugar is passed out through urine instead of staying in the bloodstream. Pakistani physicians increasingly prescribe SGLT2 inhibitors alongside metformin for patients who need better blood sugar control.

Beyond blood sugar control, Pakistani cardiologists and diabetologists value empagliflozin for its documented benefits in reducing heart failure hospitalizations and slowing kidney disease progression in people with type 2 diabetes. This makes it a useful option for patients with overlapping heart or kidney risk.

Because this medicine increases urination, Pakistani doctors advise adequate hydration, especially during hot weather or illness, to avoid dehydration and low blood pressure. Patients are also counseled to watch for signs of genital infection and to seek prompt care for unusual fatigue, nausea or abdominal pain.

Drug Class

• SGLT2 inhibitor (sodium glucose cotransporter 2 inhibitor)

Empozin Tablet 25 mg formula

• Empagliflozin 25mg

Available forms

• Tablet

How to use Empozin Tablet 25 mg?

• Empozin Tablet should be taken once daily in the morning, with or without food.
• The tablet should be swallowed whole with a glass of water.
• Adequate fluid intake helps reduce the risk of dehydration.
• This medicine should not be stopped without consulting your doctor, even if you feel well.

Drug Interactions

• Diuretics: Water pills used together with this medicine can worsen dehydration and low blood pressure.
• Insulin and Sulfonylureas: Combined use raises the risk of low blood sugar, so dose adjustment may be needed.
• ACE Inhibitors or ARBs: Concurrent use requires monitoring of kidney function and blood pressure.

Risks and warnings

• Dehydration Risk: Empagliflozin increases urination, which can cause dehydration and low blood pressure, especially in elderly patients.
• Genital Infection Risk: Increased sugar in urine raises the risk of yeast and urinary tract infections.
• Ketoacidosis Warning: Rare cases of diabetic ketoacidosis with normal blood sugar levels have been reported and require urgent medical attention.
• Kidney Function: Kidney function should be checked before starting treatment and periodically thereafter.

Empozin Tablet Side Effects

• Increased urination
• Thirst
• Urinary tract infections
• Genital yeast infections
• Low blood pressure or dizziness on standing
• Nausea
• Constipation
• Dehydration in elderly or fluid restricted patients
• Rare risk of diabetic ketoacidosis
• Rare risk of a serious genital or perineal infection called Fournier gangrene

Storage Conditions

• Store below 30°C in a dry place away from direct sunlight.
• Keep the tablets in their original blister pack until ready to use.
• Keep out of reach of children.
• Do not use beyond the expiry date printed on the pack.